These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 15841206)

  • 1. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.
    Takimoto E; Champion HC; Li M; Ren S; Rodriguez ER; Tavazzi B; Lazzarino G; Paolocci N; Gabrielson KL; Wang Y; Kass DA
    J Clin Invest; 2005 May; 115(5):1221-31. PubMed ID: 15841206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy.
    Moens AL; Takimoto E; Tocchetti CG; Chakir K; Bedja D; Cormaci G; Ketner EA; Majmudar M; Gabrielson K; Halushka MK; Mitchell JB; Biswal S; Channon KM; Wolin MS; Alp NJ; Paolocci N; Champion HC; Kass DA
    Circulation; 2008 May; 117(20):2626-36. PubMed ID: 18474817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
    Yoshioka K; Otani H; Shimazu T; Fujita M; Iwasaka T; Shiojima I
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1782-91. PubMed ID: 26408540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Zhang P; Xu X; Hu X; van Deel ED; Zhu G; Chen Y
    Circ Res; 2007 Apr; 100(7):1089-98. PubMed ID: 17363700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.
    Moens AL; Leyton-Mange JS; Niu X; Yang R; Cingolani O; Arkenbout EK; Champion HC; Bedja D; Gabrielson KL; Chen J; Xia Y; Hale AB; Channon KM; Halushka MK; Barker N; Wuyts FL; Kaminski PM; Wolin MS; Kass DA; Barouch LA
    J Mol Cell Cardiol; 2009 Nov; 47(5):576-85. PubMed ID: 19766235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.
    Ichinose F; Bloch KD; Wu JC; Hataishi R; Aretz HT; Picard MH; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1070-5. PubMed ID: 14644766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.
    Buys ES; Raher MJ; Blake SL; Neilan TG; Graveline AR; Passeri JJ; Llano M; Perez-Sanz TM; Ichinose F; Janssens S; Zapol WM; Picard MH; Bloch KD; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H620-7. PubMed ID: 17416602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cardiac mitochondrial tetrahydrobiopterin in a rat model of pressure overload.
    Shimizu S; Ishibashi M; Kumagai S; Wajima T; Hiroi T; Kurihara T; Ishii M; Kiuchi Y
    Int J Mol Med; 2013 Mar; 31(3):589-96. PubMed ID: 23313998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overload.
    van Deel ED; Octavia Y; de Boer M; Juni RP; Tempel D; van Haperen R; de Crom R; Moens AL; Merkus D; Duncker DJ
    J Mol Cell Cardiol; 2015 Nov; 88():145-54. PubMed ID: 26436984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling.
    Hashimoto T; Sivakumaran V; Carnicer R; Zhu G; Hahn VS; Bedja D; Recalde A; Duglan D; Channon KM; Casadei B; Kass DA
    J Am Heart Assoc; 2016 Mar; 5(3):e003208. PubMed ID: 27001967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase 3 deficiency limits adverse ventricular remodeling after pressure overload in insulin resistance.
    Kurtz B; Thibault HB; Raher MJ; Popovich JR; Cawley S; Atochin DN; Hayton S; Shakartzi HR; Huang PL; Bloch KD; Buys E; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2093-101. PubMed ID: 21856905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-lipid diet potentiates left ventricular dysfunction in nitric oxide synthase 3-deficient mice after chronic pressure overload.
    Ahmadie R; Santiago JJ; Walker J; Fang T; Le K; Zhao Z; Azordegan N; Bage S; Lytwyn M; Rattan S; Dixon IM; Kardami E; Moghadasian MH; Jassal DS
    J Nutr; 2010 Aug; 140(8):1438-44. PubMed ID: 20554900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation.
    Wang B; Xu M; Li W; Li X; Zheng Q; Niu X
    PLoS One; 2017; 12(6):e0179648. PubMed ID: 28622359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17beta-estradiol regulates constitutive nitric oxide synthase expression differentially in the myocardium in response to pressure overload.
    Loyer X; Damy T; Chvojkova Z; Robidel E; Marotte F; Oliviero P; Heymes C; Samuel JL
    Endocrinology; 2007 Oct; 148(10):4579-84. PubMed ID: 17673519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.
    Neilan TG; Blake SL; Ichinose F; Raher MJ; Buys ES; Jassal DS; Furutani E; Perez-Sanz TM; Graveline A; Janssens SP; Picard MH; Scherrer-Crosbie M; Bloch KD
    Circulation; 2007 Jul; 116(5):506-14. PubMed ID: 17638931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy.
    Cappola TP; Cope L; Cernetich A; Barouch LA; Minhas K; Irizarry RA; Parmigiani G; Durrani S; Lavoie T; Hoffman EP; Ye SQ; Garcia JG; Hare JM
    Physiol Genomics; 2003 Jun; 14(1):25-34. PubMed ID: 12709511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice.
    Barouch LA; Cappola TP; Harrison RW; Crone JK; Rodriguez ER; Burnett AL; Hare JM
    J Mol Cell Cardiol; 2003 Jun; 35(6):637-44. PubMed ID: 12788381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise Training Has Contrasting Effects in Myocardial Infarction and Pressure Overload Due to Divergent Endothelial Nitric Oxide Synthase Regulation.
    van Deel ED; Octavia Y; de Waard MC; de Boer M; Duncker DJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.